448
Views
9
CrossRef citations to date
0
Altmetric
Reviews

Immunotherapy for multiple myeloma

, , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Jing Yang, Ling Meng, Yongxin Yang, Hongwei Gao & Honggang Jiang. (2023) Elevated programmed cell death-1 protein/ligand (PD-1/PD-L1) and variants are associated with susceptibility to multiple myeloma: a case-control study in the Chinese cohort. Nucleosides, Nucleotides & Nucleic Acids 0:0, pages 1-19.
Read now
Paul G Richardson & Joan Bladé. (2014) The comprehensive clinical management of multiple myeloma and related-plasma cell disorders. Expert Review of Hematology 7:1, pages 1-3.
Read now

Articles from other publishers (7)

Asmaa M. Zahran, Zeinab Albadry M. Zahran & Amal Rayan. (2021) Microparticles and PD1 interplay added a prognostic impact in treatment outcomes of patients with multiple myeloma. Scientific Reports 11:1.
Crossref
Nicola Gökbuget, Jonathan Canaani, Arnon Nagler, Michael Bishop, Nicolaus Kröger & David Avigan. (2018) Prevention and treatment of relapse after stem cell transplantation with immunotherapy. Bone Marrow Transplantation 53:6, pages 664-672.
Crossref
Cindy Varga, Jacob P. Laubach, Kenneth C. Anderson & Paul G. Richardson. (2018) Investigational agents in immunotherapy: a new horizon for the treatment of multiple myeloma. British Journal of Haematology 181:4, pages 433-446.
Crossref
Jacalyn Rosenblatt & David Avigan. (2017) Targeting the PD-1/PD-L1 axis in multiple myeloma: a dream or a reality?. Blood 129:3, pages 275-279.
Crossref
Shan Meng, Chenyang Lu, Wanggang Zhang, Wenjun Shen, Yongchang Wei, Dan Su & Fuling Zhou. (2015) MMSA-1 expression pattern in multiple myeloma and its clinical significance. Clinical and Experimental Medicine 16:4, pages 599-609.
Crossref
Amrita Krishnan. (2016) How to Think About Risk in Myeloma. Clinical Lymphoma Myeloma and Leukemia 16, pages S135-S138.
Crossref
Simon Walz, Juliane S. StickelDaniel Johannes Kowalewski, Heiko Schuster, Katja WeiselLinus BackertStefan Kahn, Annika Nelde, Tatjana Stroh, Martin Handel, Oliver KohlbacherLothar KanzHelmut Rainer Salih, Hans-Georg Rammensee & Stefan Stevanović. (2015) The antigenic landscape of multiple myeloma: mass spectrometry (re)defines targets for T-cell–based immunotherapy. Blood 126:10, pages 1203-1213.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.